Aphios
MA - WoburnBiotechnology
Focus: Aphios is a small biotech firm founded in 1993 focused on small molecules and 'green' biotechnology approaches in neurology and addiction treatment. The company operates at modest scale with limited public disclosure on headcount and financial metrics.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Total Funding
$50M
Open Jobs
0
About Aphios
AI assessmentNot HiringNo open roles listed right now. Follow Aphios to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
APH-1501
Opioid AddictionClinical Trials (1)
NCT03813095Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
Phase 2Help build intelligence for Aphios
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.